MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis

Objectives To provide an integrated analysis of major adverse cardiovascular events (MACEs) and events of venous thromboembolism (VTE) and associated risk factors across rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS) phase 2b/3 upadacitinib clinical programmes....

Descrizione completa

Dettagli Bibliografici

Autori principali:	Peter Nash, Iain B McInnes, Ernest Choy, Jeffrey R Curtis, Eduardo Mysler, Christina Charles-Schoeman, Nasser Khan, Kunihiro Yamaoka, Ralph Lippe, Hannah Palac, Anna K Shmagel, Jessica Suboticki
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMJ Publishing Group 2023-10-01
Serie:	RMD Open
Accesso online:	https://rmdopen.bmj.com/content/9/4/e003392.full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!